Pfizer Earnings Beat Isn’t Enough to Ease Stock Worries
In This Article:
The drugmaker reported adjusted earnings per share of 92 cents, beating expectations of 67 cents, according to analysts polled by FactSet.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
The drugmaker reported adjusted earnings per share of 92 cents, beating expectations of 67 cents, according to analysts polled by FactSet.